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Abstract
Aims/hypothesis In diabetic children and adolescents, a
history of severe hypoglycaemia (SH) has been associated
with increased slow EEG activity and reduced cognition,
possibly due to harmful effects of SH on the developing
brain. In a group of type 1 diabetic patients with early
exposure to SH, who had EEG abnormalities and reduced
cognition in childhood, we have recently demonstrated that
the reduced cognition may persist into adulthood. We have
now assessed whether the reduced cognition was accom-
panied by lasting EEG abnormalities.
Methods In 1992–1993, we studied EEG and cognition in
28 diabetic children and 28 matched controls. 16 years
later, we re-investigated the same participants, with 96%
participation rate. Diabetic participants were classified as
with (n=9) or without (n=18) early SH, defined as episodes
with convulsions or loss of consciousness by 10 years of
age. For each EEG band (delta, theta, alpha and beta) and
cerebral region (frontocentral, temporal, and parietooccipital),
we calculated relative amplitudes and amplitude asymmetry.
Wealsocalculatedoccipitalalphameanfrequency,alphapeak
frequencyatmaximumamplitude,alphapeakwidth,andtheta
regional mean frequencies. We examined whether these EEG
measures, relative to age- and sex-matched controls, differed
between diabetic participants with and without early SH.
Results We found no association of early SH with any of
the EEG measures.
Conclusions/interpretation Childhood SH was not associ-
ated with EEG abnormalities in young type 1 diabetic
adults. Our findings suggest that the reduced adulthood
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Harmful effects of severe hypoglycaemia (SH) on the
developing brain may explain why early-onset diabetes and
exposure to SH have been associated with reduced
cognition [1], structural brain alterations and EEG abnor-
malities [2–5] in diabetic children and adolescents [6].
Recent studies suggest that reduced cognition associated
with childhood SH may persist into adulthood [7], but it is
not known if the reduced cognition is accompanied by
lasting EEG changes. In a group of type 1 diabetic patients
with early exposure to SH, we have previously reported
EEG abnormalities [2] and reduced cognition [1]i n
childhood and persistently reduced cognitive function after
16 years of follow-up [7]. We have now assessed whether
these diabetic patients with childhood exposure to SH have
EEG abnormalities in adulthood.
Methods
Study population In 1992–1993, we studied EEG [2] and
cognitive function [1] in diabetic children. Among 73
diabetic children attending Trondheim University Hospital,
the only referral centre for childhood diabetes in the region,
we included all 15 children with prior SH and 13 diabetic
children of similar age without prior SH. Each patient was
matched with a control child of same sex and age.
In 2008, the participants were invited to a follow-up
study [7] approved by the regional ethics committee.
Twenty-seven of the 28 diabetic participants and all the
original controls gave their informed consent prior to
participation.
Assessment of metabolic control and medical history All
diabetic participants attended Trondheim University Hospital
during childhood and adolescence, and 19 of them also in
adulthood. Medical history, including assessment of hypo-
glycaemic episodes, was obtained from hospital records and
by personal interview. For participants who had moved from
the region, additional information was obtained from local
physicians.
SH was defined as episodes with convulsions or loss of
consciousness. We categorised the diabetes–control pairs
into two groups according to the diabetic patient’s exposure
to early SH (≤10 years of age, n=9) or not (n=18).
All HbA1c measurements since diagnosis were recorded.
HbA1 (measured until 1989) was recalculated as HbA1c
following a method comparison at the hospital’sD e p a r t m e n t
of Clinical Chemistry. HbA1c was measured more frequently
in childhood than in adulthood. For each diabetic patient, we
therefore computed mean HbA1c for intervals of 4 years,
from which we computed an overall weighted mean HbA1c.
Quantitative EEG analysis EEG was recorded (Viasys
NicOne Nervus 5.11) and digitised (256 Hz sample rate)
from 16 scalp electrodes according to the 10–20 system,
with the participants lying relaxed and supine with closed
eyes. The participants were asked to open and close their
eyes every minute. Eye movements were recorded. Blood
glucose was measured in diabetic patients and snacks given
if glucose was low. No participants had symptomatic
hypoglycaemia during the recording.
EEG sequences without artefacts were selected and
analysed using Harmonie software (Stellate systems,
Quebec, Canada) by a clinical neurophysiologist who was
blinded with respect to the participants’ clinical status.
Recordings from frontopolar (Fp1, Fp2) and frontotemporal
(F7, F8) electrodes were excluded because of proximity to
the eyes.
A Fast-Fourier transform was applied to average-
referenced 4-s sections after cosine tapering (no overlap).
For each EEG band, i.e. the delta (0.75–3.75 Hz), theta
(4.00–7.75 Hz), alpha (8.00–12.75 Hz) and beta bands
(13.00–30.00 Hz), we calculated the average relative
amplitude (from the square root of the power in μV) within
the frontocentral (EEG locations F3, F4, C3 and C4),
temporal (T3, T4, T5 and T6), and parietooccipital (P3, P4,
O1 and O2) regions. We also calculated occipital (O1 and
O2) alpha mean frequency, alpha peak frequency at
maximum amplitude, alpha peak width, and theta regional
mean frequencies. Occipital spectra were seven-point
smoothed before peak frequency and width were calculated.
Differences in amplitudes between the hemispheres may
indicate increased EEG variability. For each EEG band and
region, we calculated an amplitude asymmetry variable as
the absolute value of the difference between amplitudes at
right and left locations, divided by the sum of amplitudes of
the right and left locations.
Statistical analyses For each relative amplitude and EEG
frequency measure, we estimated mean values among
diabetic participants with and without early SH and their
respective controls. Alpha peak width was analysed after
loge-transformation. Using a mixed linear model, we
compared each diabetic participant with his/her control
and estimated the effect of early SH, as expressed by the
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a diabetes–control pair in which the diabetic patient was
exposed to early SH. In separate analyses, we adjusted for
the diabetic patients’ blood glucose at EEG recording, but
this adjustment did not substantially influence the esti-
mates. Also, the results remained similar after exclusion of
two pairs in which the diabetes patient (one with and one
without early SH) experienced SH within 1 month prior to
EEG recording.
To examine whether early SH was associated with
amplitude asymmetry, we assessed whether the difference
in each asymmetry variable between diabetic participants
and controls differed between diabetic participants with and
without early SH, using the Mann–Whitney U test.
In additional analyses, we categorised the diabetes–
control pairs according to total number of SHs experienced
by the diabetic patient since diabetes onset (≤2, n=6; 3–
5, n=10;or≥6, n=11) and assessed whether the number of
SHs was associated with regional mean relative ampli-
tudes or EEG frequency measures, as expressed by p for
interaction between diabetes and number of SHs, using the
categories of number of SHs as a continuous variable.
Similarly, we examined whether overall mean HbA1c
(≤8.0%, n=7; 8.1–9.0%, n=12; or ≥9.1%, n=8) was
associated with relative amplitudes or EEG frequencies.
We used Kruskal–Wallis one-way analysis of variance by
r a n k st oa s s e s sa m p l i t u d ea s y m m e t r yi nr e l a t i o nt on u m b e r
of SHs and overall HbA1c.
The data were analysed using SPSS version 17.0 for
Windows (SPSS, Chicago, Illinois, USA).
Results
Characteristics of the participants are given in electronic
supplementary material (ESM) Table 1. Epileptiform
activity was not observed.
We found no association of early SH with regional mean
relative amplitudes or amplitude asymmetry in any EEG
band or cerebral region (Table 1), nor with occipital alpha
mean frequency, alpha peak frequency at maximum
amplitude, alpha peak width, or theta regional mean
frequencies (Table 2).
Total number of SHs and overall HbA1c were not
significantly associated with regional mean relative ampli-
tudes or EEG frequencies (data not shown). Also, the
Table 1 Mean relative amplitudes in diabetic participants and controls, by early
a exposure to SH, and the association of early SH with mean
relative amplitudes and amplitude asymmetry
Location Mean relative amplitudes (%) Amplitude asymmetry: p value
for association with early SH
Diabetes with early SH Diabetes without early SH Association with early SH
Diabetic participants Controls Diabetic participants Controls Difference
b 95% CI p value
c
Frontocentral region
Delta 17.1 18.1 18.9 20.6 0.7 (−3.4, 4.8) 0.73 0.30
Theta 16.9 16.6 17.7 18.5 1.1 (−2.9, 5.2) 0.57 0.10
Alpha 26.8 28.3 25.6 24.1 −3.0 (−10.0, 4.0) 0.39 0.24
Beta 39.2 37.0 37.7 36.8 1.2 (−6.4, 8.8) 0.76 0.08
Temporal region
Delta 17.6 18.8 18.6 20.0 0.2 (−3.5, 4.0) 0.90 0.92
Theta 17.6 17.2 16.8 17.8 1.4 (−2.6, 5.4) 0.48 0.57
Alpha 28.6 29.7 27.4 24.7 −3.9 (−10.4, 2.6) 0.23 0.12
Beta 36.2 34.2 37.2 37.4 2.2 (−5.2, 9.6) 0.54 0.80
Parietooccipital region
Delta 16.6 16.5 18.0 19.1 1.1 (−3.6, 5.7) 0.64 0.88
Theta 15.7 15.2 16.1 16.8 1.2 (−3.0, 5.5) 0.55 0.64
Alpha 33.3 35.4 32.6 30.4 −4.3 (−12.5, 3.8) 0.28 0.38
Beta 34.5 32.9 33.3 33.7 2.0 (−4.6, 8.7) 0.53 0.76
aBy 10 years of age
bDifference in relative amplitude (percentage points) associated with early exposure to SH, calculated as (difference between diabetic participants
with early SH and controls) − (difference between diabetic participants without early SH and controls)
cp value for interaction between having diabetes and being part of a diabetes–control pair in which the diabetic participant was exposed to
early SH
2406 Diabetologia (2011) 54:2404–2408number of SHs and overall HbA1c were not consistently
associated with amplitude asymmetry. However, a high
number of SHs was associated with asymmetry of
frontocentral alpha amplitudes (p=0.046). High HbA1c
was associated with asymmetry of frontocentral delta
amplitudes, whereas low HbA1c was associated with
asymmetry of frontocentral and temporal alpha amplitudes
(all p=0.04).
Discussion
Quantitative EEG analysis and neuropsychological testing
are two approaches to study potential cerebral damage from
early SH. When the present participants were investigated
at about 13 years of age, participants with prior SH had
increased frontocentral theta activity and reduced alpha
activity [2]. After 16 years of follow-up, however,
childhood SH was not associated with persistent EEG
abnormalities.
The present results contrast with the persistently reduced
cognition that we have recently demonstrated in these
participants with early SH [7]. Possibly, EEG abnormalities
as markers of cortical dysfunction may normalise with time
[8], even if subtle cerebral damage persists. This could
explain why reduced cognition, but not EEG abnormalities,
persisted into adulthood. Alternatively, the lack of associ-
ation between childhood SH and adulthood EEG could
support the hypothesis that impaired learning conditions in
childhood [6], rather than lasting damage from SH on
cerebral tissue, may explain the association of early SH or
early-onset diabetes with reduced adulthood cognition.
In several, but not all [9] studies, prior SH has been
associated with EEG abnormalities in diabetic children,
adolescents [2–5], and adults [10], and particularly with
globally [4, 10] or frontocentrally [2] increased slow (i.e.
delta and theta) activity. In some studies, recurrent SH or
poor metabolic control has been associated with EEG
abnormalities [3, 4, 9], but we could not reproduce these
findings. We found some evidence to suggest that number
of SHs and HbA1c were associated with amplitude
asymmetry, but these findings did not display consistent
patterns and were of borderline statistical significance, and
may be due to chance.
A strength of this study is the nearly complete
follow-up of diabetic patients and matched controls.
The participants were selected in childhood and thus,
subsequent events that may have influenced cerebral
function did not bias the selection. Recall bias is not
likely to have influenced the results, since all early SHs
were contemporarily documented in the hospital records.
The small sample size may have prevented us from
detecting minor EEG abnormalities. Participants with
early SH were younger at diabetes onset than partici-
pants without early SH (mean age 5 vs 10 years).
However, it seems unlikely that this difference may
e x p l a i nw h yw ef o u n dn oa s s o c i a t i o no fc h i l d h o o dS H
with adulthood EEG, unless early-onset diabetes could
induce EEG changes that are opposite to those associ-
ated with SH.
In summary, this 16 year follow-up study of type 1
diabetic participants suggests that the reduced adulthood
cognition related to childhood exposure to SH is not
accompanied by lasting EEG abnormalities.
Table 2 Mean EEG frequencies (Hertz) in diabetic participants and controls, by early
a exposure to SH






b 95% CI p value
c
Alpha mean frequency at occipital electrodes 10.20 10.05 10.15 10.05 0.05 −0.55, 0.65 0.86
Alpha peak frequency at maximum amplitude 10.17 9.78 10.00 9.75 0.14 −1.16, 1.44 0.83
Alpha peak width at 50% amplitude
d 1.42 1.29 1.06 1.04 8
e −42, 99 0.81
Frontocentral theta regional mean frequency 5.93 5.96 5.88 5.89 −0.01 −0.16, 0.14 0.87
Temporal theta regional mean frequency 5.95 5.95 5.89 5.90 0.01 −0.15, 0.17 0.91
Parietooccipital theta regional mean frequency 5.96 5.99 5.90 5.95 0.02 −0.16, 0.21 0.80
aBy 10 years of age
bDifference in frequency (Hz) associated with early exposure to SH, calculated as (difference between diabetic participants with early SH and
controls) − (difference between diabetic participants without early SH and controls)
cp value for interaction between having diabetes and being part of a diabetes–control pair in which the diabetic participant was exposed to
early SH
dGeometric means
ePercentage increase associated with early exposure to SH
Diabetologia (2011) 54:2404–2408 2407Acknowledgements The study was financially supported by the
Faculty of Medicine, Norwegian University of Science and Technology;
St Olavs Hospital, Trondheim University Hospital; The Norwegian
Diabetes Association; UnimedInnovationAS; sanofi-aventisNorgeA/S;
and Novo Nordisk A/S. We are indebted to the staff at our Department of
Clinical Neurophysiology for recording the EEGs and to S. Salater for
excellent practical assistance.
B.O.Å. participated in the study design, analysed and interpreted
the data, and drafted the manuscript. T.S. designed the study, analysed
and interpreted the data, and revised the manuscript. K.A.H.
participated in the study design, interpreted the data, and revised the
manuscript. M.R.B. designed the study, interpreted the data, and
revised the manuscript. All authors have approved the final version of
the manuscript.
Duality of interest The authors declare that there is no duality of
interest associated with this manuscript.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Bjorgaas M, Gimse R, Vik T, Sand T (1997) Cognitive function in
type 1 diabetic children with and without episodes of severe
hypoglycaemia. Acta Paediatr 86:148–153
2. Bjorgaas M, Sand T, Gimse R (1996) Quantitative EEG in type 1
diabetic children with and without episodes of severe hypoglycemia:
a controlled, blind study. Acta Neurol Scand 93:398–402
3. Haumont D, Dorchy H, Pelc S (1979) EEG abnormalities in
diabetic children: influence of hypoglycemia and vascular
complications. Clin Pediatr (Phila) 18:750–753
4. Hyllienmark L, Maltez J, Dandenell A, Ludvigsson J, Brismar T
(2005) EEG abnormalities with and without relation to severe
hypoglycaemia in adolescents with type 1 diabetes. Diabetologia
48:412–419
5. Soltesz G, Acsadi G (1989) Association between diabetes, severe
hypoglycaemia, and electroencephalographic abnormalities. Arch
Dis Child 64:992–996
6. Northam EA, Lin A (2010) Hypoglycaemia in childhood onset
type 1 diabetes—part villain, but not the only one. Pediatr
Diabetes 11:134–141
7. Asvold BO, Sand T, Hestad K, Bjorgaas MR (2010) Cognitive
function in type 1 diabetic adults with early exposure to severe
hypoglycemia: a 16-year follow-up study. Diabetes Care 33:1945–
1947
8. Tupola S, Saar P, Rajantie J (1998) Abnormal electroencephalo-
gram at diagnosis of insulin-dependent diabetes mellitus may
predict severe symptoms of hypoglycemia in children. J Pediatr
133:792–794
9. Hauser E, Strohmayer C, Seidl R, Birnbacher R, Lischka A,
Schober E (1995) Quantitative EEG in young diabetics. J Child
Neurol 10:330–334
10. Howorka K, Pumprla J, Saletu B, Anderer P, Krieger M,
Schabmann A (2000) Decrease of vigilance assessed by EEG-
mapping in type I diabetic patients with history of recurrent severe
hypoglycaemia. Psychoneuroendocrinology 25:85–105
2408 Diabetologia (2011) 54:2404–2408